News
News Center
2022-09-01
Jiuzhitang Maker made a strong appearance at the 6th International Conference on Immunogenetics and Cell Therapy, where Dr. Gao Yansong, General Manager, delivered an insightful presentation titled "Reflections on Pharmaceutical Development of Allogeneic Bone Marrow Mesenchymal Stem Cells"!
+
2022-01-11
Jiuzhitang Maker wins two major awards at the "2021 Brand Powerhouse Economic Forum (5th Edition)"
On January 7, 2022, the "2021 Brand Power Economic Forum & (5th) Innovation Achievement Promotion Event" was held in Hainan. Jiuzhitang Maker was invited to attend and proudly won two prestigious awards: "2021 Innovation China – Top 100 Innovative Enterprises" and "2021 Brand Power – Top 10 Innovative Enterprises in the Biopharmaceutical Industry."
+
2021-11-26
Jiuzhitang Maker was invited as one of the drafting organizations, with Chairman Zhang Quancheng and General Manager Gao Yansong participating in the drafting process.
+
2021-10-12
This year, we’ve once again made the list, earning the "2021 China Biopharmaceutical Company with the Greatest Growth Potential Award"—a testament to and recognition of our company’s remarkable breakthroughs and strong capabilities in the stem-cell field, as acknowledged by industry media and experts.
+
2021-04-14
Moving forward, we hope to leverage the "first-mover advantage" and pioneering policies of the Lecity Pilot Zone, along with its initiatives in real-world data research, to fast-track the approval and launch of Jiuzhitang's innovative products in China. By doing so, we aim to deliver valuable health solutions and services to people worldwide, solidifying our position as the public’s top-choice health partner and ultimately contributing even greater value to global human health!
+
2021-03-18
Time flies, yet our original aspirations remain unchanged—our mission still weighs heavily on our shoulders as we forge ahead with determination. In 2021, Jiuzhitang Maker, led by Chairman Zhang Quancheng and General Manager Gao Yansong, will not rest on past achievements. Instead, we’ll stay humble and focused, steadily advancing one step at a time, accelerating as we embark on this new journey!
+
2021-02-26
Jiuzhitang Maker has received investment support from the Daxing District Project for Promoting the Transfer and Transformation of Scientific and Technological Achievements, as well as financial assistance in the form of public rental housing rent subsidies.
+
2021-02-12
As the rhythm of spring returns and the warmth of sunlight gradually awakens all things, marking the beginning of a fresh new year—on the occasion of this joyous Spring Festival, all employees of Jiuzhitang Maker wish you a happy New Year, abundant blessings in everything you do, and a prosperous Year of the Ox!
+
2021-01-13
On January 12, 2021, the kickoff meeting for China's first Phase I/IIa clinical trial (ASSIST) using imported stem cells to treat ischemic stroke—initiated by Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. (hereafter referred to as "Jiuzhitang Maker")—was successfully held online at the leading institution, Beijing Tiantan Hospital Affiliated to Capital Medical University, marking the official launch of the clinical trial.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy